Top Markets
#1 Bitway Bitway +52.95%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +40.72%
#3 Pons Pons +35.43%
#4 Starpower Starpower +34.87%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.49%
#6 SkyAI SkyAI +19.55%
#7 aelf aelf +19.41%
#8 OpenEden OpenEden +19.38%
#9 Ocean Protocol Ocean Protocol +18.44%
#10 Mubarak Mubarak +18.33%
Coin of the day
Bitway Bitway
Settings
Language
ENGLISH
Currency
USD
Theme
Aton Aton

Aton

ALTAO
Rank in Stocks #30115
Based in France, Aton operates as a bioscience enterprise, with its... Based in France, Aton operates as a bioscience enterprise, with its headquarters located in Strasbourg. Established in 1998, the company's extensive operations encompass pharmaceutical research and development, the provision of preclinical and clinical services, and the creation of monoclonal antibodies. Additionally, Aton manufactures laboratory equipment, designs and produces various medical devices—including specialized surgical instruments powered by Stemcis technology—and supplies human tissues.
Share Price
$0.01802956
Market Cap
$18.17M
Change (1 day)
-9.52%
Change (1 year)
93.43%
Country
FR
Trade Aton (ALTAO)

Category

Healthcare
P/E ratio for Aton (ALTAO)
P/E ratio as of 2026 TTM: 0
According to Aton latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Aton from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.